CIK 0001158780
- Non-accelerated filer
- Smaller reporting company
Pluri Inc.
Sign in to watch- Ticker
- PLUR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 980351734
- Phone
- +972 747107171
- Business address
- MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
- Former names
- PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
- 4 Grant or award Director acquired 133,000 shares (grant or award)
- 4 Grant or award Director acquired 90,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 150,000 shares (grant or award)
- 4 Grant or award Co-CEO & President acquired 2,000,000 shares (grant or award)
- 4 Grant or award Co-CEO & Chairman acquired 2,000,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CEO & Chairman acquired 200,000 shares (grant or award)
- 4 Grant or award CFO, COO & President acquired 200,000 shares (grant or award)
- 4 Grant or award Director acquired 66,500 shares (grant or award)
- 4 Grant or award Director acquired 45,000 shares (grant or award)
- 4 Grant or award Director acquired 65,500 shares (grant or award)
- 4 Grant or award Director acquired 45,000 shares (grant or award)
- 4 Grant or award Director acquired 66,500 shares (grant or award)
- 4 Grant or award Director acquired 45,000 shares (grant or award)
- 4 Grant or award Director acquired 66,500 shares (grant or award)
- 4 Open-market sale Director sold 12,346 shares at $1.52 ($18,784)
- 4 Open-market buy CEO & Chairman bought 5,000 shares at $1.33 ($6,650)
- 4 Open-market buy CFO, COO & President bought 5,000 shares at $1.20 ($6,000)
- 4 Open-market buy CEO & Chairman bought 15,000 shares at an average $1.07 ($15,990)
- 4 Open-market buy CFO, COO & President bought 15,000 shares at an average $0.95 ($14,250)
Page 6 of 18 · 352 filings